Skip to content
10-Q

Quarterly Report

ArtVentive Medical Group, Inc.

0001056520-14-000198

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Oct 8, 2014 58.51M sh
Capex Q3 2014 · Sep 30, 2014 −$17.62K
Capex Q3 2014 · Sep 30, 2013 −$3.55K
Long Term Debt Q3 2014 · Sep 30, 2014 $500K
Cash And Equivalents Q3 2014 · Sep 30, 2014 $207.47K
Cash And Equivalents Q3 2014 · Dec 31, 2013 $1.63M
Stockholders Equity Q3 2014 · Sep 30, 2014 −$1.14M
Stockholders Equity Q3 2014 · Dec 31, 2013 $869.34K
Current Liabilities Q3 2014 · Sep 30, 2014 $1.19M
Current Liabilities Q3 2014 · Dec 31, 2013 $858.31K
Current Assets Q3 2014 · Sep 30, 2014 $457.72K
Current Assets Q3 2014 · Dec 31, 2013 $1.66M
Total Assets Q3 2014 · Sep 30, 2014 $549.98K
Total Assets Q3 2014 · Dec 31, 2013 $1.73M
Sga Expense Q3 2014 · Sep 30, 2014 $5.3M
Sga Expense Q3 2014 · Sep 30, 2013 $393.68K
Sga Expense Q3 2014 · Sep 30, 2013 $933.72K
Rd Expense Q3 2014 · Sep 30, 2014 $7.79M
Rd Expense Q3 2014 · Sep 30, 2013 $434.96K
Rd Expense Q3 2014 · Sep 30, 2013 $1.32M
Net Income Q3 2014 · Sep 30, 2014 −$4.89M
Net Income Q3 2014 · Sep 30, 2014 −$13.13M
Net Income Q3 2014 · Sep 30, 2013 −$2.25M
Operating Income Q3 2014 · Sep 30, 2014 −$13.14M
Operating Income Q3 2014 · Sep 30, 2013 −$829.22K
Operating Income Q3 2014 · Sep 30, 2013 −$2.25M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $67.5K
Revenue Q3 2014 · Sep 30, 2014 $67.5K